{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:24:44Z","timestamp":1791645884974,"version":"4.3.4"},"reference-count":360,"publisher":"The Endocrine Society","issue":"1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY008976"],"award-info":[{"award-number":["EY008976"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5UMIA110557"],"award-info":[{"award-number":["5UMIA110557"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK063121"],"award-info":[{"award-number":["DK063121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY11708"],"award-info":[{"award-number":["EY11708"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY007003"],"award-info":[{"award-number":["EY007003"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1210\/er.2018-00066","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T22:10:10Z","timestamp":1536703810000},"page":"236-267","source":"Crossref","is-referenced-by-count":213,"title":["Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy"],"prefix":"10.1210","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-9685","authenticated-orcid":false,"given":"Terry J","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, and Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A M J L","family":"Janssen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"issue":"16","key":"2019041121532354800_B1","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"2019041121532354800_B2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinte.1988.00380030132023","article-title":"Graves\u2019 disease. Influence of age on clinical findings","volume":"148","author":"Nordyke","year":"1988","journal-title":"Arch Intern Med"},{"issue":"1","key":"2019041121532354800_B3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"7","key":"2019041121532354800_B4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/bjo.86.7.740","article-title":"Ophthalmopathy in childhood Graves\u2019 disease","volume":"86","author":"Chan","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"2019041121532354800_B5","first-page":"182","article-title":"Epidemiology of Graves\u2019 orbitopathy","volume":"7","author":"Putta-Manohar","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"issue":"11","key":"2019041121532354800_B6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/bjophthalmol-2015-306733","article-title":"PREGO (presentation of Graves\u2019 orbitopathy) study: changes in referral patterns to European Group On Graves\u2019 Orbitopathy (EUGOGO) centres over the period from 2000 to 2012","volume":"99","author":"Perros","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2019041121532354800_B7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9394(14)72666-2","article-title":"The incidence of Graves\u2019 ophthalmopathy in Olmsted County, Minnesota","volume":"120","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2019041121532354800_B8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/eje.0.1480491","article-title":"Multi-center study on the characteristics and treatment strategies of patients with Graves\u2019 orbitopathy: the first European Group on Graves\u2019 Orbitopathy experience","volume":"148","author":"Prummel","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019041121532354800_B9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF03346614","article-title":"Pathogenesis of Graves\u2019 orbitopathy: a 2010 update","volume":"33","author":"Smith","year":"2010","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2019041121532354800_B10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/eye.2017.224","article-title":"The 2017 Doyne Lecture: the orbit as a window to systemic disease","volume":"32","author":"McNab","year":"2018","journal-title":"Eye (Lond)"},{"issue":"3-4","key":"2019041121532354800_B11","first-page":"177","article-title":"Development and course of exophthalmos and ophthalmoplegia in Graves\u2019 disease with special reference to the effect of thyroidectomy","volume":"5","author":"Rundle","year":"1945","journal-title":"Clin Sci"},{"issue":"6","key":"2019041121532354800_B12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jocn.2007.09.028","article-title":"Concurrent presentation of ocular myasthenia and euthyroid Graves ophthalmopathy: a diagnostic challenge","volume":"15","author":"Zouvelou","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2019041121532354800_B13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40842-016-0037-5","article-title":"Update on thyroid-associated ophthalmopathy with a special emphasis on the ocular surface","volume":"2","author":"Novaes","year":"2016","journal-title":"Clin Diabetes Endocrinol"},{"issue":"3","key":"2019041121532354800_B14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1167\/iovs.14-14002","article-title":"Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy","volume":"55","author":"Wang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2019041121532354800_B15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo.84.6.600","article-title":"Reversal of dysthyroid optic neuropathy following orbital fat decompression","volume":"84","author":"Kazim","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"2019041121532354800_B16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9394(03)00233-2","article-title":"Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients","volume":"136","author":"Soares-Welch","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"2019041121532354800_B17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.eye.6702603","article-title":"Cigarette smoking and thyroid eye disease: a systematic review","volume":"21","author":"Thornton","year":"2007","journal-title":"Eye (Lond)"},{"issue":"2","key":"2019041121532354800_B18","first-page":"542","article-title":"The incidence of ophthalmopathy after radioiodine therapy for Graves\u2019 disease: prognostic factors and the role of methimazole","volume":"79","author":"Kung","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121532354800_B19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1089\/thy.2012.0258","article-title":"Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves\u2019 ophthalmopathy and optimal timing for thyroid hormone assessment","volume":"23","author":"Stan","year":"2013","journal-title":"Thyroid"},{"issue":"3","key":"2019041121532354800_B20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1210\/jc.2016-2762","article-title":"Elevated serum tetrac in Graves disease: potential pathogenic role in thyroid-associated ophthalmopathy","volume":"102","author":"Fernando","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121532354800_B21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.beem.2011.09.005","article-title":"Treating the thyroid in the presence of Graves\u2019 ophthalmopathy","volume":"26","author":"Heged\u00fcs","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2019041121532354800_B22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2265.2008.03279.x","article-title":"Radioiodine therapy (RAI) for Graves\u2019 disease (GD) and the effect on ophthalmopathy: a systematic review","volume":"69","author":"Acharya","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2019041121532354800_B23","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves\u2019 hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"Tr\u00e4isk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"2019041121532354800_B24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM198911163212001","article-title":"Use of corticosteroids to prevent progression of Graves\u2019 ophthalmopathy after radioiodine therapy for hyperthyroidism","volume":"321","author":"Bartalena","year":"1989","journal-title":"N Engl J Med"},{"issue":"11","key":"2019041121532354800_B25","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s002680010216","article-title":"Surgery for Graves\u2019 disease: total versus subtotal thyroidectomy-results of a prospective randomized trial","volume":"24","author":"Witte","year":"2000","journal-title":"World J Surg"},{"issue":"10","key":"2019041121532354800_B26","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/thy.2005.15.1157","article-title":"Graves\u2019 disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection","volume":"15","author":"J\u00e4rhult","year":"2005","journal-title":"Thyroid"},{"issue":"5","key":"2019041121532354800_B27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrendo.2013.56","article-title":"GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis","volume":"9","author":"Simmonds","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2019041121532354800_B28","first-page":"930","article-title":"Evidence for a major role of heredity in Graves\u2019 disease: a population-based study of two Danish twin cohorts","volume":"86","author":"Brix","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B29","first-page":"536","article-title":"A population-based study of chronic autoimmune hypothyroidism in Danish twins","volume":"85","author":"Brix","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041121532354800_B30","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1210\/jc.2001-011980","article-title":"Genome-wide scan of Graves\u2019 disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees","volume":"88","author":"Jin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041121532354800_B31","doi-asserted-by":"crossref","first-page":"E1387","DOI":"10.1210\/jc.2013-4358","article-title":"Genetic analysis in young-age-of-onset Graves\u2019 disease reveals new susceptibility loci","volume":"99","author":"Brown","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041121532354800_B32","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/08820139.2017.1319382","article-title":"Role of different CD40 polymorphisms in Graves\u2019 disease and Hashimoto\u2019s thyroiditis","volume":"46","author":"Wang","year":"2017","journal-title":"Immunol Invest"},{"issue":"1","key":"2019041121532354800_B33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-0039.1982.tb01412.x","article-title":"Association of hypergammaglobulinemia G with HLA-DR3 in Graves\u2019 disease","volume":"19","author":"Briones-Urbina","year":"1982","journal-title":"Tissue Antigens"},{"key":"2019041121532354800_B34","doi-asserted-by":"crossref","first-page":"30356","DOI":"10.1038\/srep30356","article-title":"Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: a meta-analysis","volume":"6","author":"Xiong","year":"2016","journal-title":"Sci Rep"},{"key":"2019041121532354800_B35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fendo.2016.00021","article-title":"Dissecting the genetic susceptibility to Graves\u2019 disease in a cohort of patients of Italian origin","volume":"7","author":"Lombardi","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2019041121532354800_B36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-0035-1559646","article-title":"Genetics of Graves\u2019 disease: special focus on the role of TSHR gene","volume":"47","author":"Pujol-Borrell","year":"2015","journal-title":"Horm Metab Res"},{"issue":"34","key":"2019041121532354800_B37","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1073\/pnas.1408821111","article-title":"Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity","volume":"111","author":"Stefan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019041121532354800_B38","doi-asserted-by":"crossref","first-page":"E144","DOI":"10.1210\/jc.2012-2408","article-title":"Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes","volume":"98","author":"Tomer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041121532354800_B39","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2017.10.024","article-title":"Synaptic neurexin complexes: a molecular code for the logic of neural circuits","volume":"171","author":"S\u00fcdhof","year":"2017","journal-title":"Cell"},{"issue":"6939","key":"2019041121532354800_B40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"issue":"1","key":"2019041121532354800_B41","first-page":"41","article-title":"CTLA-4 gene polymorphism associated with Graves\u2019 disease in a Caucasian population","volume":"80","author":"Yanagawa","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jc.2006-2064","article-title":"Association of PTPN22 haplotypes with Graves\u2019 disease","volume":"92","author":"Heward","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019041121532354800_B43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/thy.2005.15.1119","article-title":"Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves\u2019 disease","volume":"15","author":"Kurylowicz","year":"2005","journal-title":"Thyroid"},{"issue":"5","key":"2019041121532354800_B44","doi-asserted-by":"crossref","first-page":"e0154436","DOI":"10.1371\/journal.pone.0154436","article-title":"Analysis of associations of human BAFF gene polymorphisms with autoimmune thyroid diseases","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"2019041121532354800_B45","doi-asserted-by":"crossref","first-page":"e0185529","DOI":"10.1371\/journal.pone.0185529","article-title":"Associations of melatonin receptor gene polymorphisms with Graves\u2019 disease","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2019041121532354800_B46","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1038\/srep16672","article-title":"Genetic associations of interleukin-related genes with Graves\u2019 ophthalmopathy: a systematic review and meta-analysis","volume":"5","author":"Wong","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"2019041121532354800_B47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-012513-104713","article-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics","volume":"9","author":"Tomer","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"2019041121532354800_B48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fendo.2017.00149","article-title":"Epigenetics and autoimmune thyroid diseases","volume":"8","author":"Copped\u00e8","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2019041121532354800_B49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1515\/JPEM.2002.15.8.1167","article-title":"Screening for insulin-like growth factor-I receptor mutations in patients with Silver-Russell syndrome","volume":"15","author":"Binder","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"2019041121532354800_B50","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1210\/jc.2002-021810","article-title":"Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control","volume":"88","author":"Bonaf\u00e8","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041121532354800_B51","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2003-031252","article-title":"Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity","volume":"89","author":"San Mill\u00e1n","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5-6","key":"2019041121532354800_B52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000095803","article-title":"Association of insulin-like growth factor-1 receptor polymorphism in dementia","volume":"22","author":"Garcia","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"12","key":"2019041121532354800_B53","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1158\/1055-9965.EPI-06-0541","article-title":"Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor","volume":"15","author":"Chen","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"2019041121532354800_B54","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1177\/0961203313502860","article-title":"Association of +3179G\/A insulin-like growth factor-1 receptor polymorphism and insulin-like growth factor-1 serum level with systemic lupus erythematosus","volume":"22","author":"Stanilova","year":"2013","journal-title":"Lupus"},{"issue":"4590","key":"2019041121532354800_B55","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.6298936","article-title":"Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica","volume":"219","author":"Weiss","year":"1983","journal-title":"Science"},{"issue":"2","key":"2019041121532354800_B56","first-page":"249","article-title":"Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves\u2019 disease","volume":"64","author":"Heyma","year":"1986","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"2019041121532354800_B57","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ophtha.2011.06.003","article-title":"Smoking and strabismus surgery in patients with thyroid eye disease","volume":"118","author":"Rajendram","year":"2011","journal-title":"Ophthalmology"},{"issue":"20","key":"2019041121532354800_B58","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves\u2019 orbitopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"2019041121532354800_B59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000442440","article-title":"Lack of association between selenium status and disease severity and activity in patients with Graves\u2019 ophthalmopathy","volume":"5","author":"Dehina","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"2","key":"2019041121532354800_B60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/eje.1.02210","article-title":"The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041121532354800_B61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1507\/endocrj.48.63","article-title":"High prevalence of vitamin D deficiency in Japanese female patients with Graves\u2019 disease","volume":"48","author":"Yamashita","year":"2001","journal-title":"Endocr J"},{"issue":"12","key":"2019041121532354800_B62","first-page":"4639","article-title":"Vitamin D receptor gene polymorphism is associated with Graves\u2019 disease in the Japanese population","volume":"85","author":"Ban","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041121532354800_B63","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2008.03413.x","article-title":"Vitamin D receptor (VDR) gene polymorphisms and Graves\u2019 disease: a meta-analysis","volume":"70","author":"Zhou","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019041121532354800_B64","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2265.2004.02015.x","article-title":"Lack of association of the vitamin D receptor gene with Graves\u2019 disease in UK Caucasians","volume":"60","author":"Collins","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2019041121532354800_B65","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1089\/thy.2005.15.1125","article-title":"Vitamin D receptor polymorphisms are associated with Graves\u2019 disease in German and Polish but not in Serbian patients","volume":"15","author":"Ramos-Lopez","year":"2005","journal-title":"Thyroid"},{"issue":"6","key":"2019041121532354800_B66","first-page":"2564","article-title":"A polymorphism within the vitamin D-binding protein gene is associated with Graves\u2019 disease but not with Hashimoto\u2019s thyroiditis","volume":"87","author":"Pani","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"8867","key":"2019041121532354800_B67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0140-6736(93)91475-2","article-title":"Expression of thyrotropin-receptor mRNA in healthy and Graves\u2019 disease retro-orbital tissue","volume":"342","author":"Feliciello","year":"1993","journal-title":"Lancet"},{"issue":"6","key":"2019041121532354800_B68","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1530\/eje.0.1470733","article-title":"Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues","volume":"147","author":"Agretti","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2019041121532354800_B69","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/1050725041692918","article-title":"Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function","volume":"14","author":"Sanders","year":"2004","journal-title":"Thyroid"},{"issue":"4","key":"2019041121532354800_B70","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/thy.1993.3.297","article-title":"Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves\u2019 ophthalmopathy and pretibial dermopathy","volume":"3","author":"Heufelder","year":"1993","journal-title":"Thyroid"},{"issue":"1","key":"2019041121532354800_B71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2009.0278","article-title":"A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves\u2019 orbital preadipocyte fibroblasts","volume":"20","author":"Kumar","year":"2010","journal-title":"Thyroid"},{"issue":"9","key":"2019041121532354800_B72","doi-asserted-by":"crossref","first-page":"e75100","DOI":"10.1371\/journal.pone.0075100","article-title":"Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions","volume":"8","author":"Raychaudhuri","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"2019041121532354800_B73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00060793-200210000-00006","article-title":"Fibroblast biology in thyroid diseases","volume":"9","author":"Smith","year":"2002","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"2019041121532354800_B74","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","article-title":"Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"37","key":"2019041121532354800_B75","doi-asserted-by":"crossref","first-page":"22718","DOI":"10.1074\/jbc.271.37.22718","article-title":"Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation","volume":"271","author":"Wang","year":"1996","journal-title":"J Biol Chem"},{"issue":"15","key":"2019041121532354800_B76","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1073\/pnas.95.15.8904","article-title":"Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical site-restricted cytokine-target cell interactions","volume":"95","author":"Young","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019041121532354800_B77","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1073\/pnas.91.11.5094","article-title":"Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy","volume":"91","author":"Smith","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2 Pt 1","key":"2019041121532354800_B78","doi-asserted-by":"crossref","first-page":"C382","DOI":"10.1152\/ajpcell.1995.268.2.C382","article-title":"Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts","volume":"268","author":"Smith","year":"1995","journal-title":"Am J Physiol"},{"issue":"6 Pt 1","key":"2019041121532354800_B79","doi-asserted-by":"crossref","first-page":"C1075","DOI":"10.1152\/ajpcell.1999.277.6.C1075","article-title":"Leukoregulin upregulation of prostaglandin endoperoxide H synthase-2 expression in human orbital fibroblasts","volume":"277","author":"Cao","year":"1999","journal-title":"Am J Physiol"},{"issue":"9","key":"2019041121532354800_B80","first-page":"3428","article-title":"Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture","volume":"81","author":"Sorisky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041121532354800_B81","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0002-9440(10)63488-8","article-title":"Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes","volume":"163","author":"Koumas","year":"2003","journal-title":"Am J Pathol"},{"issue":"2","key":"2019041121532354800_B82","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U","article-title":"Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes","volume":"32","author":"Koumas","year":"2002","journal-title":"Eur J Immunol"},{"issue":"19","key":"2019041121532354800_B83","doi-asserted-by":"crossref","first-page":"16355","DOI":"10.1074\/jbc.M111246200","article-title":"Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression","volume":"277","author":"Han","year":"2002","journal-title":"J Biol Chem"},{"issue":"45","key":"2019041121532354800_B84","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.273.45.29615","article-title":"Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy","volume":"273","author":"Cao","year":"1998","journal-title":"J Biol Chem"},{"issue":"8","key":"2019041121532354800_B85","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.145.8.2644","article-title":"Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis","volume":"145","author":"Roper","year":"1990","journal-title":"J Immunol"},{"issue":"1","key":"2019041121532354800_B86","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.146.1.108","article-title":"Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines","volume":"146","author":"Betz","year":"1991","journal-title":"J Immunol"},{"issue":"14","key":"2019041121532354800_B87","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1167\/iovs.17-22237","article-title":"RNA-sequencing gene expression profiling of orbital adipose-derived stem cell population implicate HOX genes and WNT signaling dysregulation in the pathogenesis of thyroid-associated orbitopathy","volume":"58","author":"Tao","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"2019041121532354800_B88","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1210\/jc.2016-1882","article-title":"IL-17A exacerbates fibrosis by promoting the proinflammatory and profibrotic function of orbital fibroblasts in TAO","volume":"101","author":"Fang","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121532354800_B89","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/105072502753600133","article-title":"Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy","volume":"12","author":"Smith","year":"2002","journal-title":"Thyroid"},{"issue":"2","key":"2019041121532354800_B90","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1167\/iovs.09-4338","article-title":"Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves\u2019 ophthalmopathy","volume":"51","author":"van Steensel","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"2019041121532354800_B91","first-page":"4079","article-title":"Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy","volume":"84","author":"Kaback","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"39","key":"2019041121532354800_B92","doi-asserted-by":"crossref","first-page":"25117","DOI":"10.1074\/jbc.273.39.25117","article-title":"Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes","volume":"273","author":"Spicer","year":"1998","journal-title":"J Biol Chem"},{"issue":"27","key":"2019041121532354800_B93","doi-asserted-by":"crossref","first-page":"24487","DOI":"10.1074\/jbc.M111.241166","article-title":"Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease","volume":"286","author":"Tsui","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"2019041121532354800_B94","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/wound.2011.0310","article-title":"Fibrocytes in fibrotic diseases and wound healing","volume":"1","author":"Grieb","year":"2012","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"2019041121532354800_B95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2016.02.008","article-title":"Fibrocyte and T cell interactions promote disease pathogenesis in rheumatoid arthritis","volume":"69","author":"Galligan","year":"2016","journal-title":"J Autoimmun"},{"issue":"11","key":"2019041121532354800_B96","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1210\/en.2015-1304","article-title":"Heme oxygenase-1 induction prevents autoimmune diabetes in association with pancreatic recruitment of M2-like macrophages, mesenchymal cells, and fibrocytes","volume":"156","author":"Husseini","year":"2015","journal-title":"Endocrinology"},{"key":"2019041121532354800_B97","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-60761-720-4_16","article-title":"Flow cytometric identification of fibrocytes in scleroderma lung disease","volume":"900","author":"Russell","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2019041121532354800_B98","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2009-1614","article-title":"Increased generation of fibrocytes in thyroid-associated ophthalmopathy","volume":"95","author":"Douglas","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019041121532354800_B99","doi-asserted-by":"crossref","first-page":"e7475","DOI":"10.1371\/journal.pone.0007475","article-title":"Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts","volume":"4","author":"Pilling","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"2019041121532354800_B100","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.94.12.6307","article-title":"The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ","volume":"94","author":"Chesney","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019041121532354800_B101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF03402138","article-title":"Interaction of Borrelia burgdorferi with peripheral blood fibrocytes, antigen-presenting cells with the potential for connective tissue targeting","volume":"5","author":"Grab","year":"1999","journal-title":"Mol Med"},{"issue":"12","key":"2019041121532354800_B102","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.4049\/jimmunol.166.12.7556","article-title":"Peripheral blood fibrocytes: differentiation pathway and migration to wound sites","volume":"166","author":"Abe","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"2019041121532354800_B103","doi-asserted-by":"crossref","first-page":"E796","DOI":"10.1210\/jc.2013-3072","article-title":"Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases","volume":"99","author":"Fernando","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041121532354800_B104","doi-asserted-by":"crossref","first-page":"E1236","DOI":"10.1210\/jc.2013-4271","article-title":"Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE","volume":"99","author":"Fernando","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"2019041121532354800_B105","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1073\/pnas.1202064109","article-title":"Human fibrocytes coexpress thyroglobulin and thyrotropin receptor","volume":"109","author":"Fernando","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019041121532354800_B106","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.4049\/jimmunol.1800259","article-title":"Slit2 modulates the inflammatory phenotype of orbit-infiltrating fiborcytes in Graves\u2019 disease","volume":"200","author":"Fernando","year":"2018","journal-title":"J Immunol"},{"issue":"6","key":"2019041121532354800_B107","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1172\/JCI117289","article-title":"Retrobulbar T cells from patients with Graves\u2019 ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts","volume":"93","author":"Grubeck-Loebenstein","year":"1994","journal-title":"J Clin Invest"},{"issue":"5","key":"2019041121532354800_B108","first-page":"1120","article-title":"Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves\u2019 ophthalmopathy","volume":"77","author":"de Carli","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B109","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2010-1424","article-title":"Regulatory T-cells in Graves\u2019 orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin","volume":"96","author":"Kahaly","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B110","first-page":"348","article-title":"Molecular cloning and characterization of genes for antibodies generated by orbital tissue-infiltrating B-cells in Graves\u2019 ophthalmopathy","volume":"78","author":"Jaume","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041121532354800_B111","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1167\/iovs.12-9861","article-title":"Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-\u03baB","volume":"53","author":"Gillespie","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2019041121532354800_B112","doi-asserted-by":"crossref","first-page":"e0162994","DOI":"10.1371\/journal.pone.0162994","article-title":"CD40 expression in fibrocytes is induced by TSH: potential synergistic immune activation","volume":"11","author":"Mester","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"2019041121532354800_B113","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1210\/jc.2011-2514","article-title":"Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production","volume":"97","author":"Gillespie","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041121532354800_B114","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40618-016-0575-9","article-title":"Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves\u2019 disease model","volume":"40","author":"Yuan","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2019041121532354800_B115","doi-asserted-by":"crossref","first-page":"E400","DOI":"10.1210\/jc.2011-2697","article-title":"Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves\u2019 ophthalmopathy","volume":"97","author":"van Steensel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121532354800_B116","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.exer.2016.05.005","article-title":"Histamine induces NF-\u03baB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1","volume":"147","author":"Virakul","year":"2016","journal-title":"Exp Eye Res"},{"issue":"8","key":"2019041121532354800_B117","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1210\/endo.140.8.6881","article-title":"HMC-1 mast cells activate human orbital fibroblasts in coculture: evidence for up-regulation of prostaglandin E2 and hyaluronan synthesis","volume":"140","author":"Smith","year":"1999","journal-title":"Endocrinology"},{"issue":"3","key":"2019041121532354800_B118","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/edrv-10-3-366","article-title":"Connective tissue, glycosaminoglycans, and diseases of the thyroid","volume":"10","author":"Smith","year":"1989","journal-title":"Endocr Rev"},{"issue":"1","key":"2019041121532354800_B119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/en.2005-1305","article-title":"Are there more than antibodies to the thyroid-stimulating hormone receptor that meet the eye in Graves\u2019 disease","volume":"147","author":"Drexhage","year":"2006","journal-title":"Endocrinology"},{"issue":"10","key":"2019041121532354800_B120","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2019041121532354800_B121","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1016\/S0021-9258(17)40123-2","article-title":"Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40","volume":"252","author":"Hopwood","year":"1977","journal-title":"J Biol Chem"},{"issue":"4937","key":"2019041121532354800_B122","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1126\/science.2556796","article-title":"Molecular cloning of the thyrotropin receptor","volume":"246","author":"Parmentier","year":"1989","journal-title":"Science"},{"key":"2019041121532354800_B123","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fendo.2017.00083","article-title":"The role of thyrotropin receptor activation in adipogenesis and modulation of fat phenotype","volume":"8","author":"Draman","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2019041121532354800_B124","doi-asserted-by":"crossref","first-page":"E1569","DOI":"10.1152\/ajpendo.00572.2011","article-title":"Expression of functional TSH receptor in white adipose tissues of hyt\/hyt mice induces lipolysis in vivo","volume":"302","author":"Endo","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2019041121532354800_B125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EJE-10-0138","article-title":"Acute exogenous TSH administration stimulates leptin secretion in vivo","volume":"163","author":"Santini","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2019041121532354800_B126","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0026-0495(99)90247-0","article-title":"Thyrotropin decreases leptin production in rat adipocytes","volume":"48","author":"Shintani","year":"1999","journal-title":"Metabolism"},{"issue":"1","key":"2019041121532354800_B127","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1210\/endo-68-1-154","article-title":"The response of hypophysectomized mice to injections of human serum containing long-acting thyroid stimulator","volume":"68","author":"Adams","year":"1961","journal-title":"Endocrinology"},{"issue":"514","key":"2019041121532354800_B128","doi-asserted-by":"crossref","first-page":"eaah4120","DOI":"10.1126\/scisignal.aah4120","article-title":"Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity","volume":"11","author":"Morshed","year":"2018","journal-title":"Sci Signal"},{"key":"2019041121532354800_B129","first-page":"160008","article-title":"Thyroid antibody-negative euthyroid Graves' ophthalmopathy","volume":"2016","author":"Tabasum","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"8","key":"2019041121532354800_B130","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/eye.2013.120","article-title":"Relevance of TSH-receptor antibody levels in predicting disease course in Graves\u2019 orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay","volume":"27","author":"Jang","year":"2013","journal-title":"Eye (Lond)"},{"issue":"2","key":"2019041121532354800_B131","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0006-291X(75)90585-9","article-title":"Comparison of thyrotrophin receptors in membranes prepared from fat and thyroid tissue","volume":"66","author":"Teng","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2019041121532354800_B132","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0090-1229(91)90075-L","article-title":"The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion","volume":"60","author":"Davies","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"issue":"4","key":"2019041121532354800_B133","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/endo.139.4.5876","article-title":"The formation of thyrotropin receptor (TSHR) antibodies in a Graves\u2019 animal model requires the N-terminal segment of the TSHR extracellular domain","volume":"139","author":"Kikuoka","year":"1998","journal-title":"Endocrinology"},{"issue":"6","key":"2019041121532354800_B134","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI7665","article-title":"Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves\u2019 disease","volume":"105","author":"Costagliola","year":"2000","journal-title":"J Clin Invest"},{"issue":"6","key":"2019041121532354800_B135","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4049\/jimmunol.168.6.2789","article-title":"A novel murine model of Graves\u2019 hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor","volume":"168","author":"Nagayama","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"2019041121532354800_B136","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.170.7.3522","article-title":"Prevention of autoantibody-mediated Graves\u2019-like hyperthyroidism in mice with IL-4, a Th2 cytokine","volume":"170","author":"Nagayama","year":"2003","journal-title":"J Immunol"},{"issue":"12","key":"2019041121532354800_B137","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","article-title":"The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim","volume":"111","author":"Chen","year":"2003","journal-title":"J Clin Invest"},{"issue":"9","key":"2019041121532354800_B138","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/eji.200324255","article-title":"Generation of a transgenic animal model of hyperthyroid Graves\u2019 disease","volume":"33","author":"Kim-Saijo","year":"2003","journal-title":"Eur J Immunol"},{"issue":"5","key":"2019041121532354800_B139","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1210\/en.2006-1077","article-title":"An improved Graves\u2019 disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB\/c mice","volume":"148","author":"Kaneda","year":"2007","journal-title":"Endocrinology"},{"issue":"3","key":"2019041121532354800_B140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/JOE-11-0162","article-title":"Orbital fibrosis in a mouse model of Graves\u2019 disease induced by genetic immunization of thyrotropin receptor cDNA","volume":"210","author":"Zhao","year":"2011","journal-title":"J Endocrinol"},{"issue":"9","key":"2019041121532354800_B141","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1210\/en.2013-1576","article-title":"Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves\u2019 orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation","volume":"154","author":"Moshkelgosha","year":"2013","journal-title":"Endocrinology"},{"issue":"4","key":"2019041121532354800_B142","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/en.2015-1829","article-title":"Comparative assessment of female mouse model of Graves\u2019 orbitopathy under different environments, accompanied by proinflammatory cytokine and T-cell responses to thyrotropin hormone receptor antigen","volume":"157","author":"Berchner-Pfannschmidt","year":"2016","journal-title":"Endocrinology"},{"issue":"9","key":"2019041121532354800_B143","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019041121532354800_B144","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1073\/pnas.1401965111","article-title":"Genomic responses in mouse models greatly mimic human inflammatory diseases","volume":"112","author":"Takao","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019041121532354800_B145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor I receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocr Rev"},{"issue":"1","key":"2019041121532354800_B146","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"issue":"6","key":"2019041121532354800_B147","first-page":"761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041121532354800_B148","first-page":"1","volume-title":"Mechanisms of Insulin Action","author":"De Meyts","year":"2007"},{"issue":"5","key":"2019041121532354800_B149","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1530\/ERC-12-0026","article-title":"Insulin and its analogues and their affinities for the IGF1 receptor","volume":"19","author":"Varewijck","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"2019041121532354800_B150","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/j.1460-2075.1986.tb04528.x","article-title":"Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity","volume":"5","author":"Ullrich","year":"1986","journal-title":"EMBO J"},{"key":"2019041121532354800_B151","doi-asserted-by":"crossref","first-page":"e03772","DOI":"10.7554\/eLife.03772","article-title":"How IGF-1 activates its receptor","volume":"3","author":"Kavran","year":"2014","journal-title":"eLife"},{"issue":"40","key":"2019041121532354800_B152","doi-asserted-by":"crossref","first-page":"14512","DOI":"10.1073\/pnas.1415475111","article-title":"Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes","volume":"111","author":"Boucher","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019041121532354800_B153","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1006\/bbrc.2000.4046","article-title":"Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain","volume":"279","author":"Lopaczynski","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"42","key":"2019041121532354800_B154","doi-asserted-by":"crossref","first-page":"39684","DOI":"10.1074\/jbc.M202766200","article-title":"Insulin\/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved","volume":"277","author":"Pandini","year":"2002","journal-title":"J Biol Chem"},{"issue":"4-5","key":"2019041121532354800_B155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000184188","article-title":"The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction","volume":"42","author":"De Meyts","year":"1994","journal-title":"Horm Res"},{"issue":"36","key":"2019041121532354800_B156","doi-asserted-by":"crossref","first-page":"25869","DOI":"10.1074\/jbc.M605189200","article-title":"Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant","volume":"281","author":"Slaaby","year":"2006","journal-title":"J Biol Chem"},{"issue":"1","key":"2019041121532354800_B157","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/157489212798357930","article-title":"Insulin-like growth factor: current concepts and new developments in cancer therapy","volume":"7","author":"King","year":"2012","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"2019041121532354800_B158","first-page":"181","volume-title":"Molecular Endocrinology, Basic Concepts and Clinical Correlations","author":"LeRoith","year":"1995"},{"key":"2019041121532354800_B159","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1507\/endocrj.43.Suppl_S49","article-title":"Control of insulin-like growth factor (IGF) action by regulation of IGF-I receptor expression","volume":"43","author":"Roberts","year":"1996","journal-title":"Endocr J"},{"key":"2019041121532354800_B160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-59259-712-3","volume-title":"The IGF System: Molecular Biology, Physiology, and Clinical Applications","author":"Rosenfeld","year":"1999"},{"issue":"3","key":"2019041121532354800_B161","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1210\/endo.133.3.7689956","article-title":"Rat pituitary GC cell insulin-like growth factor-I receptor regulation","volume":"133","author":"Yamamoto","year":"1993","journal-title":"Endocrinology"},{"issue":"3","key":"2019041121532354800_B162","first-page":"1483","article-title":"Regulation of insulin-like growth factor-binding protein expression by thyroid hormone in rat GH3 pituitary tumor cells","volume":"130","author":"Ceda","year":"1992","journal-title":"Endocrinology"},{"issue":"2","key":"2019041121532354800_B163","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2184.1994.tb01406.x","article-title":"The role of the IGF-I receptor in the growth and transformation of mammalian cells","volume":"27","author":"Baserga","year":"1994","journal-title":"Cell Prolif"},{"issue":"5","key":"2019041121532354800_B164","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/mend-5-5-678","article-title":"Fibroblast growth factor inhibits insulin-like growth factor-II (IGF-II) gene expression and increases IGF-I receptor abundance in BC3H-1 muscle cells","volume":"5","author":"Rosenthal","year":"1991","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2019041121532354800_B165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jcp.1041640126","article-title":"Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor","volume":"164","author":"DeAngelis","year":"1995","journal-title":"J Cell Physiol"},{"issue":"7","key":"2019041121532354800_B166","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/MCB.14.7.4588","article-title":"A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor","volume":"14","author":"Coppola","year":"1994","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2019041121532354800_B167","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1152\/physrev.1996.76.4.1005","article-title":"Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors","volume":"76","author":"Stewart","year":"1996","journal-title":"Physiol Rev"},{"issue":"6","key":"2019041121532354800_B168","first-page":"825","article-title":"A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro","volume":"49","author":"Salmon","year":"1957","journal-title":"J Lab Clin Med"},{"issue":"4","key":"2019041121532354800_B169","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/endo-86-4-721","article-title":"A serum fraction with \u201csulfation factor activity\u201d stimulates in vitro incorporation of leucine and sulfate into protein-polysaccharide complexes, uridine into RNA, and thymidine into DNA of costal cartilage from hypophysectomized rats","volume":"86","author":"Salmon","year":"1970","journal-title":"Endocrinology"},{"issue":"3","key":"2019041121532354800_B170","first-page":"357","article-title":"Synchronous activation of DNA synthesis in hypophysectomized rat cartilage by growth hormone","volume":"68","author":"Daughaday","year":"1966","journal-title":"J Lab Clin Med"},{"key":"2019041121532354800_B171","first-page":"741","article-title":"Conversion of proline U-C14 to labeled hydroxyproline by rat cartilage in vitro: effects of hypophysectomy, growth hormone, and cortisol","volume":"59","author":"Daughaday","year":"1962","journal-title":"J Lab Clin Med"},{"issue":"5333","key":"2019041121532354800_B172","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/235107a0","article-title":"Somatomedin: proposed designation for sulphation factor","volume":"235","author":"Daughaday","year":"1972","journal-title":"Nature"},{"issue":"2","key":"2019041121532354800_B173","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-5793(78)80237-3","article-title":"Primary structure of human insulin-like growth factor II","volume":"89","author":"Rinderknecht","year":"1978","journal-title":"FEBS Lett"},{"issue":"8","key":"2019041121532354800_B174","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0021-9258(17)40889-1","article-title":"The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin","volume":"253","author":"Rinderknecht","year":"1978","journal-title":"J Biol Chem"},{"issue":"9","key":"2019041121532354800_B175","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199702273360907","article-title":"Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors","volume":"336","author":"Le Roith","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"2019041121532354800_B176","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11487","article-title":"The IGF-1 receptor in cancer biology","volume":"107","author":"Baserga","year":"2003","journal-title":"Int J Cancer"},{"issue":"49","key":"2019041121532354800_B177","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/sj.onc.1203854","article-title":"The contradictions of the insulin-like growth factor 1 receptor","volume":"19","author":"Baserga","year":"2000","journal-title":"Oncogene"},{"issue":"2-3","key":"2019041121532354800_B178","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-978701","article-title":"Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses","volume":"31","author":"Petley","year":"1999","journal-title":"Horm Metab Res"},{"issue":"1","key":"2019041121532354800_B179","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/met.2006.4.43","article-title":"Adipogenesis and IGF-1","volume":"4","author":"Holly","year":"2006","journal-title":"Metab Syndr Relat Disord"},{"issue":"9","key":"2019041121532354800_B180","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/oby.2000.83","article-title":"Expressions of leptin and insulin-like growth factor-I are highly correlated and region-specific in adipose tissue of growing rats","volume":"8","author":"Villafuerte","year":"2000","journal-title":"Obes Res"},{"issue":"10","key":"2019041121532354800_B181","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0300-9084(02)00009-3","article-title":"Changes in IGF-I receptor and IGF-I mRNA during differentiation of 3T3-L1 preadipocytes","volume":"84","author":"Zizola","year":"2002","journal-title":"Biochimie"},{"issue":"Pt 3","key":"2019041121532354800_B182","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/bj3330825","article-title":"Expression and function of insulin\/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes","volume":"333","author":"Modan-Moses","year":"1998","journal-title":"Biochem J"},{"issue":"28","key":"2019041121532354800_B183","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1074\/jbc.M116.734194","article-title":"Unraveling growth factor signaling and cell cycle progression in individual fibroblasts","volume":"291","author":"Gross","year":"2016","journal-title":"J Biol Chem"},{"issue":"1","key":"2019041121532354800_B184","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ghir.2014.11.001","article-title":"Effects of IGFBP-1 and IGFBP-2 and their fragments on migration and IGF-induced proliferation of human dermal fibroblasts","volume":"25","author":"Brandt","year":"2015","journal-title":"Growth Horm IGF Res"},{"key":"2019041121532354800_B185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.exer.2012.11.014","article-title":"Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy","volume":"107","author":"Zhao","year":"2013","journal-title":"Exp Eye Res"},{"issue":"2","key":"2019041121532354800_B186","first-page":"637","article-title":"Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation","volume":"80","author":"Mohan","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041121532354800_B187","doi-asserted-by":"crossref","first-page":"T139","DOI":"10.1530\/JME-18-0016","article-title":"Role of IGF-binding proteins in regulating IGF responses to changes in metabolism","volume":"61","author":"Clemmons","year":"2018","journal-title":"J Mol Endocrinol"},{"issue":"6","key":"2019041121532354800_B188","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF03345225","article-title":"Circulating free insulin-like growth-factor-I (IGF-I) levels should also be measured to estimate the IGF-I bioactivity","volume":"26","author":"Janssen","year":"2003","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2019041121532354800_B189","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/jc.2012-2270","article-title":"Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves\u2019 ophthalmopathy","volume":"98","author":"Varewijck","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041121532354800_B190","first-page":"473","article-title":"Novel mechanisms of regulation of IGF-1R action: functional and therapeutic implications","volume":"10","author":"Worrall","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"issue":"3","key":"2019041121532354800_B191","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.hoc.2012.01.004","article-title":"Targeting the insulin growth factor receptor 1","volume":"26","author":"Arnaldez","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"2019041121532354800_B192","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1517\/14728222.2011.639361","article-title":"The RAS\/RAF\/MEK\/ERK and the PI3K\/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches","volume":"16","author":"De Luca","year":"2012","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"2019041121532354800_B193","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/endo.132.4.8384986","article-title":"IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3\u2032-kinase","volume":"132","author":"Myers","year":"1993","journal-title":"Endocrinology"},{"issue":"5","key":"2019041121532354800_B194","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2337\/diab.42.5.643","article-title":"The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains","volume":"42","author":"Myers","year":"1993","journal-title":"Diabetes"},{"key":"2019041121532354800_B195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/B978-0-323-18907-1.00021-4","volume-title":"Endocrinology: Adult and Pediatric","author":"Clemmons","year":"2016","edition":"7th ed."},{"issue":"13","key":"2019041121532354800_B196","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00018-013-1514-y","article-title":"Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation","volume":"71","author":"Girnita","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"2019041121532354800_B197","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fendo.2015.00064","article-title":"Targeting the IGF-1R: the tale of the tortoise and the hare","volume":"6","author":"Crudden","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"17","key":"2019041121532354800_B198","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1128\/MCB.22.17.6272-6285.2002","article-title":"Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1","volume":"22","author":"Dalle","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2019041121532354800_B199","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2017.01.052","article-title":"\u03b2-Arrestin signalling and bias in hormone-responsive GPCRs","volume":"449","author":"Reiter","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2019041121532354800_B200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"47","key":"2019041121532354800_B201","doi-asserted-by":"crossref","first-page":"82256","DOI":"10.18632\/oncotarget.19286","article-title":"Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation","volume":"8","author":"Suleymanova","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"2019041121532354800_B202","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/onc.2011.239","article-title":"Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor","volume":"31","author":"Girnita","year":"2012","journal-title":"Oncogene"},{"issue":"5","key":"2019041121532354800_B203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0022034513483142","article-title":"Periodontal disease and rheumatoid arthritis: a systematic review","volume":"92","author":"Kaur","year":"2013","journal-title":"J Dent Res"},{"issue":"15","key":"2019041121532354800_B204","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"issue":"73","key":"2019041121532354800_B205","doi-asserted-by":"crossref","first-page":"73ra19","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci Transl Med"},{"key":"2019041121532354800_B206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ceb.2015.05.005","article-title":"Effects of endocytosis on receptor-mediated signaling","volume":"35","author":"Irannejad","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"2019041121532354800_B207","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.pmbts.2016.04.001","article-title":"Chapter seven\u2014when phosphorylation encounters ubiquitination: a balanced perspective on IGF-1R signaling","volume":"141","author":"Girnita","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"5","key":"2019041121532354800_B208","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1210\/en.2012-2165","article-title":"Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction","volume":"154","author":"Sarfstein","year":"2013","journal-title":"Endocrinology"},{"issue":"16","key":"2019041121532354800_B209","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1158\/0008-5472.CAN-10-0052","article-title":"Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells","volume":"70","author":"Aleksic","year":"2010","journal-title":"Cancer Res"},{"issue":"4","key":"2019041121532354800_B210","doi-asserted-by":"crossref","first-page":"e34173","DOI":"10.1371\/journal.pone.0034173","article-title":"Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves\u2019 disease: apparent role of ADAM17","volume":"7","author":"Hoa","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"2019041121532354800_B211","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s12035-014-8824-4","article-title":"Transthyretin induces insulin-like growth factor I nuclear translocation regulating its levels in the hippocampus","volume":"51","author":"Vieira","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"19","key":"2019041121532354800_B212","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00018-009-0109-0","article-title":"Transthyretin: the servant of many masters","volume":"66","author":"Buxbaum","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"2019041121532354800_B213","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1172\/JCI115327","article-title":"Secretion of insulin-like growth factor I and insulin-like growth factor-binding proteins by murine bone marrow stromal cells","volume":"88","author":"Abboud","year":"1991","journal-title":"J Clin Invest"},{"issue":"1-2","key":"2019041121532354800_B214","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cellimm.2013.10.003","article-title":"Lymphocyte GH-axis hormones in immunity","volume":"285","author":"Weigent","year":"2013","journal-title":"Cell Immunol"},{"issue":"1","key":"2019041121532354800_B215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1359-6101(98)00022-7","article-title":"Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation","volume":"10","author":"Heemskerk","year":"1999","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"2019041121532354800_B216","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.152.9.4320","article-title":"In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation","volume":"152","author":"Jardieu","year":"1994","journal-title":"J Immunol"},{"issue":"2","key":"2019041121532354800_B217","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1172\/JCI116621","article-title":"Insulin-like growth factor-1 stimulation of lymphopoiesis","volume":"92","author":"Clark","year":"1993","journal-title":"J Clin Invest"},{"issue":"3","key":"2019041121532354800_B218","first-page":"635","article-title":"Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B cells","volume":"78","author":"Kimata","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041121532354800_B219","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/10799899209066027","article-title":"Specific insulin-like growth factor-I receptors on circulating bovine mononuclear cells","volume":"12","author":"Zhao","year":"1992","journal-title":"J Recept Res"},{"issue":"5","key":"2019041121532354800_B220","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1210\/endo.131.5.1425423","article-title":"Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells","volume":"131","author":"Kooijman","year":"1992","journal-title":"Endocrinology"},{"issue":"4","key":"2019041121532354800_B221","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2265.1998.00557.x","article-title":"The IGF-I\/IGFBP system in congenital partial lipodystrophy","volume":"49","author":"Janssen","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019041121532354800_B222","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/joe.0.1470203","article-title":"Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes","volume":"147","author":"Kooijman","year":"1995","journal-title":"J Endocrinol"},{"issue":"11","key":"2019041121532354800_B223","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.4049\/jimmunol.154.11.5736","article-title":"T cell development in insulin-like growth factor-II transgenic mice","volume":"154","author":"Kooijman","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"2019041121532354800_B224","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/eji.1830250411","article-title":"Differential expression of type I insulin-like growth factor receptors in different stages of human T cells","volume":"25","author":"Kooijman","year":"1995","journal-title":"Eur J Immunol"},{"issue":"2","key":"2019041121532354800_B225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/cimm.1997.1237","article-title":"Downregulation of insulin-like growth factor-1 receptor (IGF-1R) expression in human T lymphocyte activation","volume":"183","author":"Schillaci","year":"1998","journal-title":"Cell Immunol"},{"issue":"5","key":"2019041121532354800_B226","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jcem-72-5-1117","article-title":"Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes","volume":"72","author":"Stuart","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"2-3","key":"2019041121532354800_B227","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0303-7207(89)90211-6","article-title":"Functional receptors for insulin-like growth factors I and II in rat thymocytes and mouse thymoma cells","volume":"67","author":"Verland","year":"1989","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2019041121532354800_B228","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/endo.143.4.8725","article-title":"Igf-I inhibits spontaneous apoptosis in human granulocytes","volume":"143","author":"Kooijman","year":"2002","journal-title":"Endocrinology"},{"issue":"11","key":"2019041121532354800_B229","first-page":"2243","article-title":"The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells","volume":"7","author":"Reiss","year":"1992","journal-title":"Oncogene"},{"issue":"3","key":"2019041121532354800_B230","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1172\/JCI113703","article-title":"Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro","volume":"82","author":"Tapson","year":"1988","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041121532354800_B231","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4049\/jimmunol.148.1.63","article-title":"Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes","volume":"148","author":"Johnson","year":"1992","journal-title":"J Immunol"},{"issue":"3","key":"2019041121532354800_B232","first-page":"394","article-title":"Expression of functional insulin-like growth factor-1 receptor on lymphoid cell subsets of rats","volume":"85","author":"Xu","year":"1995","journal-title":"Immunology"},{"issue":"10","key":"2019041121532354800_B233","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.4049\/jimmunol.145.10.3497","article-title":"Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype","volume":"145","author":"Gjerset","year":"1990","journal-title":"J Immunol"},{"issue":"2","key":"2019041121532354800_B234","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.V83.2.361.361","article-title":"Native associations of early hematopoietic stem cells and stromal cells isolated in bone marrow cell aggregates","volume":"83","author":"Funk","year":"1994","journal-title":"Blood"},{"issue":"2","key":"2019041121532354800_B235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/edrv.18.2.0296","article-title":"The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function","volume":"18","author":"Clark","year":"1997","journal-title":"Endocr Rev"},{"issue":"10","key":"2019041121532354800_B236","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V82.10.3005.3005","article-title":"Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells","volume":"82","author":"Gibson","year":"1993","journal-title":"Blood"},{"issue":"5","key":"2019041121532354800_B237","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V80.5.1207.1207","article-title":"Insulin-like growth factor-I regulates pro-B cell differentiation","volume":"80","author":"Landreth","year":"1992","journal-title":"Blood"},{"issue":"5","key":"2019041121532354800_B238","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1165\/ajrcmb\/4.5.432","article-title":"Activated alveolar macrophages express the insulin-like growth factor-I receptor","volume":"4","author":"Rom","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"2019041121532354800_B239","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0898-6568(03)00069-X","article-title":"IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase","volume":"15","author":"Kooijman","year":"2003","journal-title":"Cell Signal"},{"issue":"2","key":"2019041121532354800_B240","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/joe.0.1490351","article-title":"IGF-I potentiates interleukin-2 production in human peripheral T cells","volume":"149","author":"Kooijman","year":"1996","journal-title":"J Endocrinol"},{"issue":"4","key":"2019041121532354800_B241","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1189\/jlb.0404248","article-title":"Insulin-like growth factor-I stimulates IL-10 production in human T cells","volume":"76","author":"Kooijman","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2019041121532354800_B242","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.178.5.3281","article-title":"Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves\u2019 disease may carry functional consequences for disease pathogenesis","volume":"178","author":"Douglas","year":"2007","journal-title":"J Immunol"},{"issue":"8","key":"2019041121532354800_B243","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.4049\/jimmunol.181.8.5768","article-title":"B Cells from patients with Graves\u2019 disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis","volume":"181","author":"Douglas","year":"2008","journal-title":"J Immunol"},{"issue":"12","key":"2019041121532354800_B244","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves\u2019 disease is mediated through the insulin-like growth factor I receptor pathway","volume":"170","author":"Pritchard","year":"2003","journal-title":"J Immunol"},{"issue":"5","key":"2019041121532354800_B245","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jc.2008-2810","article-title":"Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves\u2019 disease: evidence for a phenotypic signature ascribable to nongenetic factors","volume":"94","author":"Douglas","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B246","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1530\/acta.0.1280168","article-title":"The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes","volume":"128","author":"Nyman","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1-2","key":"2019041121532354800_B247","first-page":"15","article-title":"Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells","volume":"57","author":"Auernhammer","year":"2002","journal-title":"Horm Res"},{"issue":"5","key":"2019041121532354800_B248","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/1043-2760(93)90107-P","article-title":"Influence of thyroid hormones on the GH-IGF-I axis","volume":"4","author":"Rodriguez-Arnao","year":"1993","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2019041121532354800_B249","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2265.1983.tb00007.x","article-title":"Growth hormone secretion and plasma somatomedin-C in primary hypothyroidism","volume":"19","author":"Chernausek","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2019041121532354800_B250","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1210\/endo-125-6-2905","article-title":"Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat","volume":"125","author":"Wolf","year":"1989","journal-title":"Endocrinology"},{"issue":"1","key":"2019041121532354800_B251","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-72-1-108","article-title":"Nature of altered growth hormone secretion in hyperthyroidism","volume":"72","author":"Iranmanesh","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121532354800_B252","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1210\/endo-125-5-2385","article-title":"Pituitary insulin-like growth factor-I gene expression: regulation by triiodothyronine and growth hormone","volume":"125","author":"Fagin","year":"1989","journal-title":"Endocrinology"},{"issue":"1","key":"2019041121532354800_B253","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/endo-126-1-550","article-title":"Thyroid hormone regulates rat pituitary insulin-like growth factor-I receptors","volume":"126","author":"Matsuo","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121532354800_B254","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/CBO9780511549304.018","volume-title":"Growth Hormone in Adults: Physiological and Clinical Aspects","author":"Jorgensen","year":"2000"},{"issue":"1","key":"2019041121532354800_B255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/jcem-36-1-103","article-title":"Inhibition of thyrotropin releasing hormone-mediated secretion of thyrotropin by human growth hormone","volume":"36","author":"Root","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041121532354800_B256","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1210\/jcem-40-4-612","article-title":"Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone","volume":"40","author":"Lippe","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121532354800_B257","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.1994.tb01826.x","article-title":"Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults","volume":"41","author":"J\u00f8rgensen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2019041121532354800_B258","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-69-6-1127","article-title":"Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism","volume":"69","author":"J\u00f8rgensen","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121532354800_B259","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/jcem-67-5-1111","article-title":"The acute effects of human growth hormone administration on thyroid function in normal men","volume":"67","author":"Grunfeld","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B260","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1210\/endo-102-2-606","article-title":"Serum somatomedin stimulation in thyroxine-treated hypophysectomized rats","volume":"102","author":"Gaspard","year":"1978","journal-title":"Endocrinology"},{"issue":"6","key":"2019041121532354800_B261","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0022-2828(92)91047-9","article-title":"Differential regulation of insulin-like growth factor I by growth hormone and thyroid hormone in the heart of juvenile hypophysectomized rats","volume":"24","author":"Kupfer","year":"1992","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"2019041121532354800_B262","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biopha.2007.04.002","article-title":"Thyroid hormone receptor and IGF1\/IGFR systems: possible relations in the human heart","volume":"61","author":"Sabatino","year":"2007","journal-title":"Biomed Pharmacother"},{"issue":"1-2","key":"2019041121532354800_B263","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-012-1345-4","article-title":"Regulation of insulin-like growth factors and their binding proteins by thyroid stimulating hormone in human osteoblast-like (SaOS2) cells","volume":"368","author":"Ramajayam","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"2019041121532354800_B264","first-page":"836","volume-title":"The Thyroid","author":"Snyder","year":"1996","edition":"7th ed."},{"issue":"6","key":"2019041121532354800_B265","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0022-3476(89)80439-1","article-title":"Attenuation of spontaneous, nocturnal growth hormone secretion in children with hypothyroidism and its correlation with plasma insulin-like growth factor I concentrations","volume":"114","author":"Chernausek","year":"1989","journal-title":"J Pediatr"},{"issue":"4","key":"2019041121532354800_B266","first-page":"950","article-title":"Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins","volume":"76","author":"Miell","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121532354800_B267","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2265.1995.tb02923.x","article-title":"Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone","volume":"43","author":"Ramos-Dias","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019041121532354800_B268","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF03349528","article-title":"Concentrations of somatomedin-C and triiodothyronine in patients with thyroid dysfunction and nonthyroidal illnesses","volume":"13","author":"V\u00e4lim\u00e4ki","year":"1990","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2019041121532354800_B269","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF03348744","article-title":"Thyroid hormones and growth hormone secretion","volume":"15","author":"Valcavi","year":"1992","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2019041121532354800_B270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1677\/jme.0.0100313","article-title":"Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight\/body weight change during abnormal thyroid function","volume":"10","author":"Thomas","year":"1993","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"2019041121532354800_B271","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.0.1400251","article-title":"Changes in hepatic insulin-like growth factor-binding proteins -1, -2 and -3 mRNA levels in rats with altered thyroid status","volume":"140","author":"Rodriguez-Arnao","year":"1994","journal-title":"J Endocrinol"},{"issue":"1","key":"2019041121532354800_B272","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1677\/jme.0.0100007","article-title":"Tri-iodothyronine and cycloheximide enhance insulin-like growth factor-binding protein-1 gene expression in human hepatoma cells","volume":"10","author":"Angervo","year":"1993","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"2019041121532354800_B273","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/105072501753271734","article-title":"Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction","volume":"11","author":"Iglesias","year":"2001","journal-title":"Thyroid"},{"issue":"2","key":"2019041121532354800_B274","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2265.2000.00924.x","article-title":"Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism","volume":"52","author":"Jenkins","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5 Pt 1","key":"2019041121532354800_B275","first-page":"E840","article-title":"Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats","volume":"269","author":"Frystyk","year":"1995","journal-title":"Am J Physiol"},{"issue":"3","key":"2019041121532354800_B276","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3181\/00379727-216-44182","article-title":"Insulin-like growth factor binding protein-1: recent findings and new directions","volume":"216","author":"Lee","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"2019041121532354800_B277","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ghir.2003.12.015","article-title":"The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment","volume":"14","author":"Zimmermann-Belsing","year":"2004","journal-title":"Growth Horm IGF Res"},{"issue":"s1","key":"2019041121532354800_B278","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000329191","article-title":"Insulin-like growth factor I: pros and cons of a bioassay","volume":"76","author":"Janssen","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"2019041121532354800_B279","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0300-595X(72)80037-9","article-title":"Insulin and insulin-like substances in the circulation","volume":"1","author":"Lazarus","year":"1972","journal-title":"Clin Endocrinol Metab"},{"issue":"7","key":"2019041121532354800_B280","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1210\/jc.2007-2454","article-title":"Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays","volume":"93","author":"Brugts","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B281","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1210\/endo-119-2-940","article-title":"Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves\u2019-IgG","volume":"119","author":"Tramontano","year":"1986","journal-title":"Endocrinology"},{"issue":"4","key":"2019041121532354800_B282","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1210\/jcem-57-4-782","article-title":"Characterization of the optimal stimulatory effects of graves\u2019 monoclonal and serum immunoglobulin G on adenosine 3\u2032,5\u2032-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay","volume":"57","author":"Vitti","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121532354800_B283","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI113672","article-title":"Thyroid-stimulating hormone and insulin-like growth factor-1 synergize to elevate 1,2-diacylglycerol in rat thyroid cells. Stimulation of DNA synthesis via interaction between lipid and adenylyl cyclase signal transduction systems","volume":"82","author":"Brenner-Gati","year":"1988","journal-title":"J Clin Invest"},{"issue":"3","key":"2019041121532354800_B284","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves\u2019 disease immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041121532354800_B285","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1210\/endo.142.12.8534","article-title":"Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-Ir receptor in the thyroid gland","volume":"142","author":"Cl\u00e9ment","year":"2001","journal-title":"Endocrinology"},{"issue":"6","key":"2019041121532354800_B286","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol"},{"issue":"12","key":"2019041121532354800_B287","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1096\/fj.13-231381","article-title":"IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter","volume":"27","author":"Ock","year":"2013","journal-title":"FASEB J"},{"issue":"11","key":"2019041121532354800_B288","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1210\/me.2011-0065","article-title":"TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia","volume":"25","author":"M\u00fcller","year":"2011","journal-title":"Mol Endocrinol"},{"issue":"5","key":"2019041121532354800_B289","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/me.2013-1377","article-title":"Wnt-independent role of \u03b2-catenin in thyroid cell proliferation and differentiation","volume":"28","author":"Sastre-Perona","year":"2014","journal-title":"Mol Endocrinol"},{"issue":"5","key":"2019041121532354800_B290","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/db11-1578","article-title":"A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control","volume":"61","author":"Bhaskar","year":"2012","journal-title":"Diabetes"},{"issue":"6","key":"2019041121532354800_B291","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1530\/acta.0.1210753","article-title":"Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates","volume":"121","author":"Guler","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"13","key":"2019041121532354800_B292","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1002\/j.1460-2075.1987.tb02743.x","article-title":"Monoclonal antibodies to the insulin receptor stimulate the intrinsic tyrosine kinase activity by cross-linking receptor molecules","volume":"6","author":"O\u2019Brien","year":"1987","journal-title":"EMBO J"},{"issue":"7","key":"2019041121532354800_B293","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1016\/S0021-9258(17)43059-6","article-title":"The role of antireceptor antibodies in stimulating phosphorylation of the insulin receptor","volume":"259","author":"Zick","year":"1984","journal-title":"J Biol Chem"},{"issue":"4","key":"2019041121532354800_B294","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1476-5381.2010.01094.x","article-title":"Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor","volume":"162","author":"Cazorla","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2019041121532354800_B295","doi-asserted-by":"crossref","first-page":"e88684","DOI":"10.1371\/journal.pone.0088684","article-title":"Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity","volume":"9","author":"Corbin","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2019041121532354800_B296","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08916939309014643","article-title":"Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy","volume":"16","author":"Weightman","year":"1993","journal-title":"Autoimmunity"},{"issue":"2","key":"2019041121532354800_B297","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Igs from patients with Graves\u2019 disease induce the expression of T cell chemoattractants in their fibroblasts","volume":"168","author":"Pritchard","year":"2002","journal-title":"J Immunol"},{"issue":"4","key":"2019041121532354800_B298","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/en.2005-1375","article-title":"Immunoglobulin G from patients with Graves\u2019 disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease","volume":"147","author":"Gianoukakis","year":"2006","journal-title":"Endocrinology"},{"issue":"2","key":"2019041121532354800_B299","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/jc.2012-1771","article-title":"Autoantibodies to the IGF1 receptor in Graves\u2019 orbitopathy","volume":"98","author":"Minich","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041121532354800_B300","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1210\/jc.2016-1315","article-title":"TSH\/IGF-1 receptor cross talk in Graves\u2019 ophthalmopathy pathogenesis","volume":"101","author":"Krieger","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041121532354800_B301","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1089\/thy.2017.0281","article-title":"Response to Krieger et al. re: \u201cTSHR\/IGF-1R cross-talk, not IGF-1R stimulating antibodies, mediates Graves\u2019 ophthalmopathy pathogenesis\u201d (Thyroid 2017;27:746\u2013747)","volume":"27","author":"Smith","year":"2017","journal-title":"Thyroid"},{"key":"2019041121532354800_B302","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1749-6632.1986.tb20865.x","article-title":"Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves\u2019 disease","volume":"475","author":"Kohn","year":"1986","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"2019041121532354800_B303","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.tips.2007.09.007","article-title":"GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation","volume":"28","author":"Delcourt","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"2019041121532354800_B304","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.tips.2011.04.002","article-title":"Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow","volume":"32","author":"Pyne","year":"2011","journal-title":"Trends Pharmacol Sci"},{"issue":"28","key":"2019041121532354800_B305","doi-asserted-by":"crossref","first-page":"16495","DOI":"10.1074\/jbc.270.28.16495","article-title":"G beta gamma subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor","volume":"270","author":"Luttrell","year":"1995","journal-title":"J Biol Chem"},{"issue":"19","key":"2019041121532354800_B306","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1074\/jbc.M010884200","article-title":"Insulin and insulin-like growth factor I receptors utilize different G protein signaling components","volume":"276","author":"Dalle","year":"2001","journal-title":"J Biol Chem"},{"issue":"51","key":"2019041121532354800_B307","doi-asserted-by":"crossref","first-page":"51334","DOI":"10.1074\/jbc.M309968200","article-title":"Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis","volume":"278","author":"Povsic","year":"2003","journal-title":"J Biol Chem"},{"issue":"48","key":"2019041121532354800_B308","doi-asserted-by":"crossref","first-page":"31640","DOI":"10.1074\/jbc.273.48.31640","article-title":"beta-Arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor","volume":"273","author":"Lin","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"2019041121532354800_B309","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/thy.1994.4.155","article-title":"High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain","volume":"4","author":"Nagayama","year":"1994","journal-title":"Thyroid"},{"issue":"7","key":"2019041121532354800_B310","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/endo.136.7.7789342","article-title":"The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt\/hyt mouse results in plasma membrane targeting but defective TSH binding","volume":"136","author":"Gu","year":"1995","journal-title":"Endocrinology"},{"issue":"2","key":"2019041121532354800_B311","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0021-9258(17)36130-6","article-title":"Insulin-like growth factors I and II in fetal and adult bovine serum. Purification, primary structures, and immunological cross-reactivities","volume":"261","author":"Honegger","year":"1986","journal-title":"J Biol Chem"},{"issue":"4","key":"2019041121532354800_B312","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"2019041121532354800_B313","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","article-title":"Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves\u2019 orbitopathy","volume":"97","author":"Bartalena","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121532354800_B314","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-14-0712","article-title":"Intravenous glucocorticoid therapy for Graves\u2019 ophthalmopathy and acute liver damage: an epidemiological study","volume":"172","author":"Sisti","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2019041121532354800_B315","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00417-016-3280-7","article-title":"Efficacy of combined orbital radiation and systemic steroids in the management of Graves\u2019 orbitopathy","volume":"254","author":"Kim","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2019041121532354800_B316","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.1987.tb00836.x","article-title":"Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves\u2019 ophthalmopathy: a comparative study","volume":"27","author":"Marcocci","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1-4","key":"2019041121532354800_B317","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000180698","article-title":"Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves\u2019 ophthalmopathy","volume":"26","author":"Pinchera","year":"1987","journal-title":"Horm Res"},{"issue":"3","key":"2019041121532354800_B318","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/radiology.196.3.7644656","article-title":"Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids","volume":"196","author":"Nakahara","year":"1995","journal-title":"Radiology"},{"issue":"2","key":"2019041121532354800_B319","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-37-2-276","article-title":"Supervoltage orbital radiotherapy for Graves\u2019 ophthalmopathy","volume":"37","author":"Donaldson","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2019041121532354800_B320","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJM197404042901414","article-title":"Letter: Orbital radiotherapy for the ophthalmopathy of Graves\u2019s disease","volume":"290","author":"Donaldson","year":"1974","journal-title":"N Engl J Med"},{"issue":"6","key":"2019041121532354800_B321","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2265.1980.tb03422.x","article-title":"An evaluation of supervoltage orbital irradiation for Graves\u2019 ophthalmopathy","volume":"13","author":"Teng","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121532354800_B322","first-page":"339","article-title":"Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves\u2019 ophthalmopathy","volume":"80","author":"DeGroot","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041121532354800_B323","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2003-030809","article-title":"A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves\u2019 ophthalmopathy","volume":"89","author":"Prummel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041121532354800_B324","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","article-title":"A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves\u2019 ophthalmopathy","volume":"108","author":"Gorman","year":"2001","journal-title":"Ophthalmology"},{"issue":"10","key":"2019041121532354800_B325","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archopht.1984.01040031193016","article-title":"Radiation retinopathy after orbital irradiation for Graves\u2019 ophthalmopathy","volume":"102","author":"Kinyoun","year":"1984","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"2019041121532354800_B326","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archopht.121.5.652","article-title":"Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy","volume":"121","author":"Robertson","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"2019041121532354800_B327","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0167-8140(95)01670-8","article-title":"Probable risk of tumour induction after retro-orbital irradiation for Graves\u2019 ophthalmopathy","volume":"38","author":"Snijders-Keilholz","year":"1996","journal-title":"Radiother Oncol"},{"issue":"1","key":"2019041121532354800_B328","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0360-3016(01)01754-0","article-title":"A long-term follow-up study after retro-orbital irradiation for Graves\u2019 ophthalmopathy","volume":"52","author":"Schaefer","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2019041121532354800_B329","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2003-030260","article-title":"Long-term safety of orbital radiotherapy for Graves\u2019 ophthalmopathy","volume":"88","author":"Marcocci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019041121532354800_B330","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","article-title":"Orbital irradiation for Graves\u2019 ophthalmopathy: is it safe? A long-term follow-up study","volume":"111","author":"Wakelkamp","year":"2004","journal-title":"Ophthalmology"},{"issue":"8877","key":"2019041121532354800_B331","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(93)92001-A","article-title":"Randomized double-blind trial of prednisone versus radiotherapy in Graves\u2019 ophthalmopathy","volume":"342","author":"Prummel","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"2019041121532354800_B332","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000309924","article-title":"Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves\u2019 ophthalmopathy","volume":"197","author":"Wiersinga","year":"1988","journal-title":"Ophthalmologica"},{"issue":"10","key":"2019041121532354800_B333","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF03347943","article-title":"Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves\u2019 ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study","volume":"14","author":"Marcocci","year":"1991","journal-title":"J Endocrinol Invest"},{"issue":"21","key":"2019041121532354800_B334","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1056\/NEJMct1114348","article-title":"Anti-CD20 antibody therapy for B-cell lymphomas","volume":"366","author":"Maloney","year":"2012","journal-title":"N Engl J Med"},{"issue":"1-2","key":"2019041121532354800_B335","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10354-014-0331-8","article-title":"Efficacy and safety of rituximab in rheumatic diseases","volume":"165","author":"Rath","year":"2015","journal-title":"Wien Med Wochenschr"},{"issue":"5","key":"2019041121532354800_B336","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/eje.1.02140","article-title":"The rationale for B lymphocyte depletion in Graves\u2019 disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option","volume":"154","author":"El Fassi","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019041121532354800_B337","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(03)00032-4","article-title":"B-cell depletion with rituximab-a targeted therapy for Graves\u2019 disease and autoimmune thyroiditis","volume":"88","author":"Hasselbalch","year":"2003","journal-title":"Immunol Lett"},{"issue":"4","key":"2019041121532354800_B338","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1530\/eje.1.02119","article-title":"Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression","volume":"154","author":"Salvi","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019041121532354800_B339","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2014-3014","article-title":"Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves\u2019 orbitopathy: a randomized controlled study","volume":"100","author":"Salvi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B340","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jc.2014-2572","article-title":"Randomized controlled trial of rituximab in patients with Graves\u2019 orbitopathy","volume":"100","author":"Stan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121532354800_B341","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/IOP.0000000000000037","article-title":"Treatment of active corticosteroid-resistant graves\u2019 orbitopathy","volume":"30","author":"P\u00e9rez-Moreiras","year":"2014","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"5","key":"2019041121532354800_B342","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/bjo.2010.192302","article-title":"Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves\u2019 ophthalmopathy","volume":"95","author":"van Steensel","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"2019041121532354800_B343","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fendo.2017.00179","article-title":"Thyroid autoimmunity and function after treatment with biological antirheumatic agents in rheumatoid arthritis","volume":"8","author":"Bliddal","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2019041121532354800_B344","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","article-title":"Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves\u2019 orbitopathy (MINGO): a randomised, observer-masked, multicentre trial","volume":"6","author":"Kahaly","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2019041121532354800_B345","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2019041121532354800_B346","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1210\/jcem.86.7.7634","article-title":"Clinical perspective: acromegaly and cancer: a problem","volume":"86","author":"Jenkins","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121532354800_B347","first-page":"108","article-title":"Acromegaly and cancer","volume":"62","author":"Jenkins","year":"2004","journal-title":"Horm Res"},{"key":"2019041121532354800_B348","first-page":"104","volume-title":"Insulin-like Growth Factors","author":"Baserga","year":"2003"},{"issue":"50","key":"2019041121532354800_B349","doi-asserted-by":"crossref","first-page":"20620","DOI":"10.1073\/pnas.1216348110","article-title":"\u03b2-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing\u2019s sarcoma","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"2019041121532354800_B350","first-page":"8912","article-title":"A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo","volume":"63","author":"Burtrum","year":"2003","journal-title":"Cancer Res"},{"issue":"8474","key":"2019041121532354800_B351","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(86)90698-7","article-title":"Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin","volume":"1","author":"Hansson","year":"1986","journal-title":"Lancet"},{"issue":"4","key":"2019041121532354800_B352","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1590\/S0004-27492008000400004","article-title":"Protein expression of VEGF, IGF-1 and FGF in retroocular connective tissues and clinical correlation in Graves\u2019 ophthalmopathy","volume":"71","author":"Matos","year":"2008","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"2019041121532354800_B353","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00417-011-1876-5","article-title":"Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy","volume":"250","author":"Song","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"18","key":"2019041121532354800_B354","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"2019041121532354800_B355","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/jc.2013-1004","article-title":"Is IGF-I receptor a target for autoantibody generation in Graves\u2019 disease","volume":"98","author":"Smith","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2019041121532354800_B356","doi-asserted-by":"crossref","first-page":"29501","DOI":"10.18632\/oncotarget.15704","article-title":"Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"2019041121532354800_B357","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.4049\/jimmunol.173.5.3564","article-title":"Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves\u2019 disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor","volume":"173","author":"Pritchard","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"2019041121532354800_B358","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08916934.2014.976631","article-title":"Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis","volume":"48","author":"Suzuki","year":"2015","journal-title":"Autoimmunity"},{"issue":"5","key":"2019041121532354800_B359","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/08916934.2017.1344970","article-title":"Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis","volume":"50","author":"Tsushima","year":"2017","journal-title":"Autoimmunity"},{"issue":"2","key":"2019041121532354800_B360","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/pr.109.002469","article-title":"Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases","volume":"62","author":"Smith","year":"2010","journal-title":"Pharmacol Rev"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/40\/1\/236\/27509513\/er.2018-00066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T01:14:56Z","timestamp":1693876496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/40\/1\/236\/5094009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":360,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,11]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2018-00066","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,9,11]]}}}